InvestorsChronicle of the WeekEnjoy an income fiesta with this bankThe lender has traditionally dashed for growth but its focus on cost control and payouts suggests it is embracing a more moderate paceSave11 July 2024
InvestorsChronicle of the WeekAdd style to your portfolio with this all-American brandThe 57-year-old name has successfully navigated the various ages of fashion and is once again pulling ahead of its rivalsSave11 July 2024
InvestorsChronicle of the WeekClean up with this Aim stalwartThis laundry group is in recovery mode after a turbulent few years Save4 July 2024
InvestorsChronicle of the WeekThis FTSE flop has further to fall After some bad news from Canada, these shares are on a downward spiralSave4 July 2024
InvestorsChronicle of the WeekA diversified drugmaker with an edge over rivalsIt focuses on niche products and high-growth markets and doesn't bring the R&D risk of larger pharma stocksSave27 June 2024
InvestorsChronicle of the WeekA reformed small cap with a resilient business modelThe data and training provider is reaping the rewards of investments it made during the pandemic Save20 June 2024
InvestorsChronicle of the WeekThis smart miner is winning the race for resourcesMining ‘tourists’ have backed off this month, making it a good time to buy into this diversified major Save20 June 2024
InvestorsChronicle of the WeekPay attention to this maturing income stockHaving turned its back on huge acquisitions, this life insurer plans to settle down and pay out high dividends Save13 June 2024
InvestorsChronicle of the WeekThis overpriced tech giant is threatened by AIBillions of dollars of stock-based compensation could hit free cash flow in the near future Save13 June 2024
InvestorsChronicle of the WeekA clever and cheap way to invest in private equityThis multi-asset investment trust could prove a bargain if you like private assets, dividends and steady growthSave6 June 2024